| Effects of muscarinic acetylcholine m1 and m4 receptor blockade on dyskinesia in the hemi-parkinsonian rat NE Chambers, SM Meadows, A Taylor, E Sheena, K Lanza, MM Conti, ... Neuroscience 409, 180-194, 2019 | 47 | 2019 |
| Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia K Lanza, SM Meadows, NE Chambers, E Nuss, MM Deak, S Ferré, ... Neuropharmacology 138, 304-314, 2018 | 41 | 2018 |
| Pedunculopontine nucleus degeneration contributes to both motor and non-motor symptoms of Parkinson’s disease NE Chambers, K Lanza, C Bishop Frontiers in Pharmacology 10, 486278, 2020 | 36 | 2020 |
| Serotonergic targets for the treatment of L-DOPA-induced dyskinesia K Lanza, C Bishop Journal of Neural Transmission 125 (8), 1203-1216, 2018 | 32 | 2018 |
| Diverse serotonin actions of vilazodone reduce l‐3, 4‐dihidroxyphenylalanine–induced dyskinesia in hemi‐parkinsonian rats SM Meadows, MM Conti, L Gross, NE Chambers, Y Avnor, CY Ostock, ... Movement Disorders 33 (11), 1740-1749, 2018 | 23 | 2018 |
| Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia K Lanza, A Centner, M Coyle, I Del Priore, FP Manfredsson, C Bishop Experimental Neurology 336, 113534, 2021 | 15 | 2021 |
| Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat K Lanza, K Chemakin, S Lefkowitz, C Saito, N Chambers, C Bishop Psychopharmacology 237, 155-165, 2020 | 11 | 2020 |
| Late aging–associated increases in L-DOPA–induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat K Lanza, AE Perkins, T Deak, C Bishop Neurobiology of aging 81, 190-199, 2019 | 10 | 2019 |
| Modulation of nigral dopamine signaling mitigates parkinsonian signs of aging: evidence from intervention with calorie restriction or inhibition of dopamine uptake MF Salvatore, EA Kasanga, DP Kelley, KE Venable, TR McInnis, ... GeroScience 45 (1), 45-63, 2023 | 9 | 2023 |
| Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats NE Chambers, M Coyle, J Sergio, K Lanza, C Saito, B Topping, SD Clark, ... European Journal of Neuroscience 53 (8), 2835-2847, 2021 | 8 | 2021 |
| Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia K Lanza, C Bishop Biomedicines 9 (3), 314, 2021 | 8 | 2021 |
| Pedunculopontine nucleus degeneration contributes to both motor and non-motor symptoms of Parkinson’s disease. Front. Pharmacol. 10, 1494 NE Chambers, K Lanza, C Bishop | 5 | 2019 |
| Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats CY Kiessling, K Lanza, E Feinberg, C Bishop Neuropharmacology 174, 108138, 2020 | 4 | 2020 |
| Rostral Pedunculopontine Nucleus Infusion of M4 Positive Allosteric Modulator VU0467154 Augments L-DOPA Effects in Hemiparkinsonian Rats NE Chambers, A MClune, M Coyle, A Centner, J Sergio, I Del Priore, ... bioRxiv, 2024.04. 16.589785, 2024 | | 2024 |
| Compartment-specific blockade of dopamine uptake in nigrostriatal pathway reveals role for nigral dopamine function in movement frequency in open-field M Salvatore, E Kasanga, K Lanza, S Meadows, A Centner, C Bishop MOVEMENT DISORDERS 35, S230-S231, 2020 | | 2020 |
| Investigating the Role of Dopamine D1 Receptor and D3 Receptor Cooperativity in Dyskinesia K Lanza State University of New York at Binghamton, 2020 | | 2020 |
| Contribution of pedunculopontine nucleus cholinergic neurons to L-DOPA-induced dyskinesia and PD motor deficits in hemi-parkinsonian rats N Chambers, J Sergio, C Saito, K Lanza, C Bishop MOVEMENT DISORDERS 34, S329-S329, 2019 | | 2019 |
Christopher BishopProfessor at Binghamton UniversityVerified email at binghamton.edu
